Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-3058 10% Nail Solution in Onychomycosis
NCT02549001Phase 3Completed
- Sponsor
- Polichem
- Start
- Aug 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 13
01
Overview
Phase 3, randomised, double-blind trial of Terbinafine in onychomycosis (3 arms), sponsored by Polichem. Primary endpoint: Complete cure of target great toenail at Week 60. Started Aug 2015; status: completed.
02
Drugs
Terbinafine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT02549001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549001.